Tirzepatide in Houston, Tx
Tirzepatide Weight loss Injections in Humble, Kingwood, New Caney, Atascocita, Spring, Woodlands, Houston, Tx.
“Welcome to Alim Wellness Clinic: A weight loss clinic in Houston! We are excited to announce that we now offer Tirzepatide weight loss injections as part of our comprehensive weight loss program. Our team of experienced weight loss doctors will work with you to create a personalized weight loss plan that includes diet and exercise recommendations, as well as weekly Tirzepatide injections program. Tirzepatide has been shown to help people lose body weight significantly, and we are confident that our program can help you achieve your weight loss goals. Contact us today to schedule a consultation and learn more about our weight loss services.”
We offer weight loss services for people living in Humble, Kingwood, New Caney, Atascocita, Spring, Woodlands, Houston, Tx.
The drug maker Eli Lilly announced on April 27 that Tirzepatide has shown striking results in two clinical trials. The once-weekly injectable prescription medication helped overweight people lose up to 15% of their body weight.
Tirzepatide is currently in Phase 3 clinical trials for weight loss in adults who are overweight, obese or have weight related health issues. Tirzepatide has received FDA Fast Track designation to speed up its path for FDA submission for treating adults with obesity, or overweight with weight-related health conditions.
In the SURMOUNT-1 clinical trial the average weight loss after 72 weeks was 15% for the 5mg dose, 19.5% for the 10mg dose and 20.9% for the 15mg dose.
Tirzepatide is not FDA approved as a weight loss medication yet. However your doctor can decide if Tirzepatide is better than other weight loss drugs based on your unique situation.
What is Tirzepatide?
Tirzepatide is a once-weekly injection that is FDA-approved to be used to decrease blood sugar (blood glucose) in adults who have type 2 diabetes. It should be used together with diet and exercise. Tirzepatide has also been shown in clinical trials to be useful for weight loss. Expect a approval from FDA for weight loss soon.
How is Tirzepatide different from Ozempic?
Tirzepatide is the first dual GIP/GLP-1 receptor agonist which means it works on the glucose-dependent insulinotropic polypeptide (GIP) receptors and the glucagon-like peptide-1 (GLP-1) receptors. In clinical trials, weight loss achieved with Tirzepatide was much more than Semaglutide like compounds.
What are common side effects of Tirzepatide?
Everyone can have a different experience, but here are the most common side effects experienced by patients taking Tirzepatide:
In studies, most nausea, vomiting and diarrhea events occurred while the dose of Tirzepatide was being increased. These events decreased over time.